Literature DB >> 9649697

Lidocaine-prilocaine cream (EMLA Cream) as a topical anaesthetic for the cleansing of leg ulcers. The effect of length of application time.

R G Holst1, A Kristofferson.   

Abstract

Pain prevents the effective cleansing of many leg ulcers. Pain relief during debridement has been reported after topical anaesthesia with EMLA cream. The purpose of this study was to assess and compare the pain intensity during debridement after different lengths of application time of EMLA. Fifty-nine patients, stratified for leg ulcer type, were randomised to 10, 20 or 60 minutes treatment with EMLA prior to debridement. The pain was rated by each patient on a 100-mm visual analogue scale (VAS). Pain intensity during debridement decreased significantly with increasing duration of EMLA application (p = 0.001). The median values of the VAS pain scores were 41, 20 and 8 in the 10-, 20- and 60- minute groups respectively. A minimum of 20 minutes application time gives substantial pain relief in the majority of patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9649697

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  4 in total

1.  EMLA anaesthetic cream for debridement of burns: a study of plasma concentrations of lidocaine and prilocaine and a review of the literature.

Authors:  Stefan Lillieborg; Leif Aanderud
Journal:  Int J Burns Trauma       Date:  2017-10-25

2.  Percutaneous dermal drug delivery for local pain control.

Authors:  Sujatha Tadicherla; Brian Berman
Journal:  Ther Clin Risk Manag       Date:  2006-03       Impact factor: 2.423

Review 3.  Topical agents or dressings for pain in venous leg ulcers.

Authors:  Michelle Briggs; E Andrea Nelson; Marrissa Martyn-St James
Journal:  Cochrane Database Syst Rev       Date:  2012-11-14

4.  Dressings and topical agents for arterial leg ulcers.

Authors:  Cathryn Broderick; Fania Pagnamenta; Rachel Forster
Journal:  Cochrane Database Syst Rev       Date:  2020-01-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.